NCT00734097 - A Study of Nexium (Esomeprazole) 40 mg Once Daily in Subjects With Symptoms of Gastroesophageal Reflux Disease (GORD) After Treatment With a Full Dose of Proton Pump Inhibitor (PPI) | Biotech Hunter

Enrollment

314

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions

Gastroesophageal Reflux Disease

Interventions

DRUG

Esomeprazole 40 mg

Once a day

PROCEDURE

Physical Exam

every visit

OTHER

Quality of Life Questionnaires

every visit

PROCEDURE

pregnancy test, if applicable

as needed

Trial Locations (10)

Research Site, Buenos Aires

Research Site, Santiago

Research Site, Temuco

Research Site, Viña del Mar

Research Site, Barranquilla

Research Site, Bogotá

Research Site, Medellín

Research Site, Barquisimeto

Research Site, Caracas

Research Site, San Cristóbal